Keyuan Pharmaceutical Keyuan Pharmaceutical

Stock Code: 301281
Confirm

Keyuan News

Video Center

NEWS CENTER

Company Strength

Keyuan Group Conducts Company-Wide Training on Integrity and Compliance, Strengthening the Pharmaceutical Company’s Integrity Defense Line

Keyuan Group Conducts Company-Wide Training on Integrity and Compliance, Strengthening the Pharmaceutical Company’s Integrity Defense Line

2026-05-20

Keyuan Group Conducts Company-Wide Training on Integrity and Compliance, Strengthening the Pharmaceutical Company’s Integrity Defense Line

To thoroughly implement the latest requirements of the Criminal Law Amendment (No. 12), effectively strengthen all employees’ awareness of integrity and compliance, prevent and mitigate internal risks of official misconduct, and safeguard the company’s high-quality development, on May 20, Keyuan Group organized a company-wide training session on corruption prevention and compliance. Led by the Human Resources Center and the Audit Center, the event adopted a hybrid online–offline format to ensure full coverage, mandatory participation, and comprehensive learning for all employees.

2026-05-20

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating intelligent manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed strong recognition of its practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.

2026-05-17

Dual Exhibitions on One Stage, Full-Chain Collaboration | Keyuan Pharmaceutical, together with its subsidiary Linuo Pharmaceutical, jointly showcased at the Shanghai International Pharmaceutical Dual Exhibitions!

On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediates, Packaging, and Equipment Fair (API China) opened simultaneously at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing synergistic raw material–formulation integration, end-to-end product displays, and brand resonance. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore new industry trends, expand avenues for collaboration, and build a new ecosystem for the pharmaceutical and healthcare sectors.

2026-05-13